NSE/Alb as a Prognostic Biomarker for Lung Cancer

NCT03724604 · clinicaltrials.gov ↗

UNKNOWN

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DIAGNOSTIC_TEST: Neuron-Specific Enolase to Albumin Ratio

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]